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INTRODUCTION
Acanthosis nigricans is a skin disorder characterized
by dark, thick, velvety plaque of the skin which usually
occurs in body folds but may involve other parts of
the body 1. It is commonly seen on the neck, in the
armpit and groin. It could also be found on the elbow,
knee and knuckles 2,3,4. It is a disorder found commonly
among the African descents with darker skin
pigmentation. It is a disorder that may begin at any
age and has no gender differences 5. It can affect
otherwise healthy people or be associated with
underlying medical disease 3. Although, the actual cause
is unknown, it is most likely caused by factors that
stimulate epidermal keratinocyte and dermal fibroblast
proliferation. There are two broad categories of
acanthosis nigricans namely; benign and malignant. In
the benign form of  acanthosis nigricans, some cases
are genetically inherited. The mode of inheritance has
not been established, however, autosomal recessive
or polygenic inheritance has been proposed 6.
Acanthosis nigricans is most commonly associated with
being overweight (BMI >25 kg/m²) and it is frequently
found in people with diabetes 7-10. The stimulating
factor is probably insulin or an insulin-like growth
factor that incites the epidermal cell propagation.
Hyperinsulinemia results in binding of insulin to insulin-
like growth factor receptors on keratinocytes and
fibroblasts, with resultant hyperplasia of the skin 11.
Insulin resistance due to obesity underlies the
hyperinsulinemia in obesity-associated acanthosis
nigricans 12, 13. Sometimes acanthosis nigricans is due
to other forms of  endocrine (glandular) disorder such
as polycystic ovary syndrome, acromegaly, pituitary or
adrenal adenomas, and cushing syndrome 14. It could
also result from the use of exogenous drugs like
hormones (contraceptive pills), cytotoxics, steroid, large
dose of  niacin etc 1, 15. The malignant form is by far
less common and the patients with this type tend to
be thin and older than 40 years of age, and their
eruption is usually of recent origin 16,17. The stimulating
factor in malignant acanthosis nigricans is hypothesized
to be a substance secreted either by the tumor or in
response to the tumor. Transforming growth factor-
alpha is structurally similar to epidermal growth factor
and it has been implicated 18-20. Acanthosis nigricans is
rarely associated with a tumor and if it does, unusually
severe. Development of acanthosis nigricans may be
the first clue to an underlying neoplastic process in an
otherwise healthy adult. Ninety percent of the
neoplasms responsible for the development of
acanthosis nigricans originate in the abdomen 21.
Nonetheless, there is no information on acanthosis
nigricans among the head and neck patients in our
environment. Hence, our aim is to describe the pattern
of  presentation of  acanthosis nigricans, to determine
its prevalence and to identify the underlying associated
medical and oncologic factors among head and neck
patients managed at department of
Otorhinolaryngology, University College Hospital,
Ibadan.
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ABSTRACT
Background: The sudden appearance of acanthosis nigricans on
the skin of an individual is highly suggestive of an underlying
clinical disease. However, there is no information on its possible
association with head and neck disease in our environment.
Objective: To determine the prevalence of  acanthosis nigricans
and identifying the underlying associated medical and oncologic
factor in an Otorhinolaryngologic, head and neck practice.
Method: This was a 12-month prospective study of patients seen
at Otorhinolaryngology department of  University College
Hospital, Ibadan. Relevant clinical, anthropometric and
biochemical information were obtained with an interviewer assisted
questionnaire and data analyzed using descriptive statistics.
Results: Of 764 patients, 85(11.13%) had head and neck
malignancies, 15(1.96%) had diabetes mellitus in addition to the
Otorhinolaryngologic, head and neck diseases. The body mass
index values for male and female ranged from 18.26 – 25.68kg/m²
and 17.94 – 30.25kg/m² respectively. Only two patients, one with
nasopharyngeal cancer and the other with obesity in addition to
chronic rhinosinusitis had acanthosis nigricans.
Conclusion:  Acanthosis nigricans is not common among
Otorhinolaryngologic patients in our clinical setting with a
prevalence of 0.003. Nevertheless, its presence should herald the
suspicion of an underlying metabolic or oncologic disease.
Keywords: Acanthosis Nigricans, Otorhinolaryngology, Head, Neck
                                                   Annals of Ibadan Postgraduate  Medicine. Vol.6 No.1 June, 2008      53
MATERIALS AND METHOD
A prospective study of all patients that presented to
the ENT clinic and ward of University College
Hospital, Ibadan from August 2005 to August 2006
was carried out. An understood informed consent was
obtained from all the patients that participated in the
study. A structured interview assisted questionnaire was
used to collect the biodata (Age, Sex, and Nationality),
Ear, nose and throat disease, history of presence of a
thick dark area on the skin, and the duration for which
it had been noticed. History of diabetes mellitus,
malignancy, and use of  cytotoxics, hormonal drugs
(oral contraceptives) and steroids were obtained. All
the patients had their head and neck region, armpits,
breasts, elbow, groin, knees and knuckles examined
for presence of  acanthosis nigricans. The weight (Kg)
and height (m) of the patients were measured to
determine their body mass index. All the patients with
history of diabetes mellitus had fasting plasma glucose
done. Data were analyzed using descriptive statistics.
RESULTS
There were seven hundred and sixty four patients; 347
(45.42%) males and 417(54.58%) females with age
ranged between 3 and 63 years old and overall mean
age of  47.78 and standard deviation of  21.08 (Table
1). There were 85(11.13%) patients with head and neck
malignancies, 47(55.29%) males and 38(44.71%)
females (Table 2). Forty six (54.12%) patients had
sinonasal cancer, 17(20%) had nasopharyngeal cancer,
3(3.53%) had ear cancer, 12(14.12%) had laryngeal
cancer. Three (3.53%) patients had metastatic neck
disease. One of the female patients with
nasopharyngeal cancer had acanthosis nigricans around
the neck folds.
Table 1: Age range distribution of  participants
Table 2: Distribution of  head and neck malignancies
and acanthosis nigricans
There were 15(1.96%) patients, Five (33.33%) males
and 10(66.67%) female with associated diabetes
mellitus in addition to the head and neck lesion. All
had their fasting blood sugar checked and were all
within normal limit. Two patients with diabetes mellitus
had associated head and neck malignancy
(nasopharyngeal and laryngeal cancer). The body mass
index values for male ranged from 18.26–25.68 kg/
m² while that of female ranged from 17.94–30.25
kg/m². Sixteen (2.09%) of the patients were
overweight with body mass index >25 kg/m² (8males
and 8females). One of the female obese patients
(BMI=30.25 kg/m²) with chronic rhinosinusitis had
acanthosis nigricans in her armpit and under the breast
folds. Thirteen (6.60%) female patients had history of
usage of contraceptive pills for average period of 4
months (range 2 – 9 months). Twenty-one (2.75%) of
the patients had history of treatment with cytotoxic
drugs. The head and neck disease distribution in our
patients is shown in Table 3.
Discussion
Acanthosis nigricans is a rare disease. It is not in itself
dangerous but it can be associated with a potentially
dangerous diseases. The actual prevalence of  the disease
is unknown. Various researchers had reported different
prevalence of the disease in different regions of the
world 7, 22. Acanthosis nigricans is much more common
in people with darker skin pigmentation 9. The
prevalence in whites is less than 1%. In Hispanics, the
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Age range(YRS) Frequency Percentage (%)
1 – 10 69 9.03
11 – 20 67 8.77
21 – 30 169  22.12
31 – 40 229 29.97
41 – 50 163 21.33
51 – 60 58 7.59
61 – 70 9 1.19
Total 764 100.00
Site of  Tumour Frequency      Presence/
                    Absence of
                    AN
Sinonasal 16 (18.82%) -
Larynx 18 (21.18%) -
Nasopharynx 24 (28.23%) 1
Ear 3 (3.53%) -
Metastatic neck disease 4 (4.71%) -
Oropharynx 3(3.53%) -
Mandible 6 (7.06%) -
Oral Cavity 3(3.53%) -
Hypopharynx 5 (5.88%) -
Parotid 3(3.53%) -
Total 85(100.00%) 1
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prevalence is 5.5%, and, in African Americans, the
prevalence is the highest at 13.3% 7, 9, 22. However, in
this study, the prevalence of  acanthosis nigricans among
head and neck patients was 0.003%. This low
prevalence rate might be due to the fact that most of
our patients were without the previously documented
associated factor of  acanthosis nigricans. In addition,
there was non availability of a similar study among
head and neck patients for comparison. A previous
study had reported 2 out of 12,000 patients with
internal malignancy having acanthosis nigricans 21. In
our series, only one patient with head and neck
malignancy had acanthosis nigricans. Although, no
gender inequality had been reported, the two cases of
acanthosis nigricans seen in this study were female.
Acanthosis nigricans can occur at any age; however,
the malignant type is usually seen above the age of 40
years 18-20, 23. This is in agreement with what was found
in this study as our patient with nasopharyngeal tumor
who had acanthosis nigricans was 42 years old. The
presentation of acanthosis nigricans is common at the
body folds especially on the neck, in the armpit and
groin. This is the case in this study as it was found
exclusively around the patient’s neck fold.
The benign type of acanthosis nigricans is commoner
than the malignant type. Normal range of  BMI
according to WHO are 18.5 – 24.9 kg/m².
Overweight is e” 25 kg/m². Obese individual has a
BMI of >30 kg/m² and this is associated with a great
morbidity. Sixteen (2.09%) of  our patients in this study
were overweight but only one obese patients had
acanthosis nigricans in her armpit and under the breast
folds. The head and neck disease in this patient was
chronic rhinosinusitis. In addition, the fifteen patients
with diabetes mellitus were already on medications and
their blood sugar also controlled. Treatment of
underlying causes of acanthosis nigricans may prevent
its development and usually results in its resolution 21.
There were thirteen (5.04%) patients with the history
of having used oral contraceptive pills for average of
4 months. None of  these patients showed evidence
of acanthosis nigricans on their skin. The reason for
these could actually be as a result of  short term usage
or because they had stopped the usage of the
medication for an average period of 3 years 8 months
before they were seen and recruited into this study.
This is a good enough time for the skin lesion to have
cleared if it was actually present on their skin.
In conclusion, Acanthosis nigricans is a rare
dermatologic condition in our Otorhinolaryngologic
practice with a prevalence of 0.003. Its identification
on the skin of patients presenting to the
Otorhinolaryngologic clinic must not be casually
dismissed without searching for possible associated
underlying metabolic or oncologic disorder. The early
detection of an underlying disease will in no doubt
result in a better treatment outcome.
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